Delivery Order SPE2DE24D0013-SPE2D626F268D
- Not listed
- The Defense Logistics Agency, through its Medical Supply Chain organization, awarded a delivery order valued at $1,277.84 to Cepheid Inc. (UEI: W6HQTMWB9Q28) on July 21, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. The delivery order represents a continuation of Cepheid's established relationship with federal defense and healthcare agencies as...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $27,650.40 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025. This firm fixed-price delivery order, designated XPRSMVP-10 with completion targeted for November 20, 2025, represents a procurement of diagnostic testing supplies and reagents under an existing indefinite delivery contract vehicle. The award carries no set-aside designation,...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $13,825.20 firm fixed-price delivery order to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California. This delivery order, issued on September 19, 2025, with an ultimate completion date of September 26, 2025, carries no set-aside designation and represents a procurement of diagnostic equipment or testing supplies. The award leverages Cepheid's expertise in advanced...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $13.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, with an ultimate completion date of October 3, 2025. This delivery order, which carries no set-aside designation, represents a continuation of the federal government's procurement of Cepheid's diagnostic testing capabilities and equipment. Cepheid specializes in advanced...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $12,694.80 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on September 9, 2025, for molecular diagnostic testing solutions. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by September 16, 2025, and will be performed at Cepheid's Sunnyvale, California facility. This award carries no set-aside designation and represents a routine procurement under the company's existing...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a $3,638 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on May 30, 2025, with an ultimate completion date of June 13, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, carries no set-aside designation and is for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus detection. The work will be performed at Cepheid's facility in...
- The Defense Logistics Agency has awarded a $13.6K delivery order (XPRS4PLEX-10) to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, awarded on September 11, 2025, with an ultimate completion date of September 18, 2025, represents a continuation of the federal government's procurement of Cepheid's diagnostic testing capabilities. The award carries no set-aside designation and will be performed at Cepheid's...
- The Defense Logistics Agency (DLA), under the Medical Supply Chain program, awarded a delivery order valued at $1,648.38 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on August 12, 2025. This firm fixed-price delivery order, without set-aside designation, represents a continuation of Cepheid's ongoing provision of diagnostic testing solutions to federal defense and healthcare agencies. The contract is scheduled for ultimate completion by August 19, 2025,...
- This delivery order, valued at $1,104.00, was awarded to Cepheid Inc. on November 3, 2025, by the Defense Logistics Agency Medical Supply Chain for performance in Sunnyvale, California, with an ultimate completion date of November 10, 2025. The contract utilizes a firm fixed-price pricing structure with no set-aside designation. As a single delivery order under what appears to be an existing indefinite delivery contract vehicle, this award represents a continuation of Cepheid's role as a primary...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a delivery order valued at $52,387.20 to Cepheid Inc. on September 26, 2025, with an ultimate completion date of October 3, 2025. This firm fixed-price delivery order (contract number 4569624736, XPRS4PLEX-10) carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. The award represents a discrete purchase under one of Cepheid's larger indefinite delivery...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F268DDelivery Order
This delivery order, valued at $1,277.84, was awarded on November 18, 2025, to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents. The award is a firm fixed-price delivery order with no set-aside designation, utilizing a Defense Logistics Agency Medical Supply Chain contract vehicle. Based on Cepheid's established federal portfolio, this delivery order likely involves diagnostic testing supplies, reagents, or test kits for infectious disease detection, consistent with the company's core competency in molecular diagnostics including COVID-19, influenza, tuberculosis, and other clinical conditions. Performance is scheduled for completion by November 25, 2025, at the company's Sunnyvale location. Cepheid has established itself as a primary federal supplier of diagnostic solutions across multiple federal healthcare agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and Defense Logistics Agency. The company holds significant indefinite delivery contracts, notably a $32.8 million IDC with VA VISN 6 extending through 2030 and a $6.7 million IDC with VA VISN 17 through 2029, which serve as ongoing procurement vehicles for molecular diagnostic testing supplies. These contracts underscore the federal government's reliance on Cepheid's GeneXpert diagnostic platform and associated testing capabilities to support clinical laboratory operations and infectious disease testing requirements across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/18/25 |